MPLT
MapLight Therapeutics, Inc. · Healthcare
Chief Executive Officer Christopher A. Kroeger sold $1.9M of MapLight Therapeutics, Inc.
Sold$1,949,634
$28.47Price
68,491Shares
−4%Stake
What MPLT did after the filing
- The stock from Tue, May 12 open, $29.45
- +8.5%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Jun 25 close.
Traded Mon, May 11. Filed Mon, May 11, 9:30 PM ET, after the close. Returns use the May 12 open and the Jun 25 close. Not investment advice.